GlassScriptPhysician profile
Cory M Buschmann
NPI 1407293103
$13,701.94
in general payments reported to CMS, 2019-2025
70 companies · $2,493 in 2025
The $2,493 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.18 · 2020: $798 · 2021: $1,972 · 2022: $2,150 · 2023: $3,000 · 2024: $3,259 · 2025: $2,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,702 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,701.87 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,623.62 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $1,534.64 | 2020-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $1,301.33 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $867.42 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $824.39 | 2021-2025 | |
| Abbott Laboratories | $644.74 | 2021-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $641.08 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $562.03 | 2020-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $416.51 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Novartis Pharmaceuticals Corporation | $309.00 | 2023-2025 | |
| Eisai INC. | $269.84 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $262.65 | 2020-2025 | Spravato, Xarelto |
| Medtronic, INC. | $249.50 | 2021-2024 | Abre, Micra |
| Biosense Webster, INC. | $240.64 | 2024 | Carto 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $207.68 | 2020-2021 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.22 | 2022-2025 | Ofev, Jardiance |
| Astellas Pharma US INC | $155.31 | 2020-2025 | Veozah, Myrbetriq |
| Almatica Pharma LLC | $141.55 | 2023-2024 | Loreev Xr |
| Biohaven Pharmaceuticals, INC. | $141.50 | 2021 | |
| Antares Pharma, INC. | $130.56 | 2021-2022 | |
| Corcept Therapeutics | $114.58 | 2022-2025 | Korlym |
| Gilead Sciences, INC. | $109.39 | 2022-2025 | |
| Sanofi Pasteur INC. | $99.68 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $95.70 | 2022 | |
| Merck Sharp & Dohme LLC | $94.91 | 2020-2025 | Dificid, Zerbaxa, Gardasil 9 |
| Cleerly, INC. | $82.33 | 2024 | Cleerly Labs |
| Therapeuticsmd, INC. | $79.95 | 2020-2022 | |
| Impel Pharmaceuticals INC. | $73.17 | 2022-2023 | Trudhesa |
| Dexcom, INC. | $71.81 | 2022-2023 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $71.16 | 2024-2025 | Voquezna |
| Edwards Lifesciences Corporation | $70.83 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Axsome Therapeutics, INC. | $64.69 | 2024-2025 | Auvelity |
| Amarin Pharma, INC. | $63.77 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $63.68 | 2023-2024 | Nexletol, Contrave |
| Neuronetics, INC. | $58.01 | 2020 | |
| Sumitomo Pharma America, INC. | $57.94 | 2024-2025 | Gemtesa |
| Itamar Medical INC | $56.78 | 2022-2023 | Watchpatone |
| Optinose US, INC. | $42.72 | 2022 | |
| Boston Scientific Corporation | $40.22 | 2023-2024 | Ams 700 Cxr Rte Kit |
| Esperion Therapeutics, INC. | $38.78 | 2021-2023 | Nexletol |
| Genzyme Corporation | $35.03 | 2023 | |
| Hologic Sales and Service, LLC | $34.81 | 2021-2024 | Aptima |
| Globus Medical, INC. | $32.57 | 2024 | Simplify Cervical Artificial Disc |
| Actelion Pharmaceuticals US, INC. | $30.43 | 2025 | Uptravi, Opsumit, Opsynvi |
| Azurity Pharmaceuticals, INC. | $28.71 | 2023 | Edarbi |
| Genentech USA, INC. | $26.29 | 2020 | |
| Millicent US INC | $24.28 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $21.44 | 2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $20.94 | 2021 | |
| Exact Sciences Corporation | $20.81 | 2025 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $19.78 | 2023 | Tirosint, Licart |
| Sonex Health, INC. | $18.00 | 2024-2025 | Sx-One Microknife |
| Idorsia Pharmaceuticals US INC | $17.50 | 2023 | Quviviq |
| Intuity Medical INC | $17.19 | 2022 | |
| Verity Pharmaceuticals INC. | $16.40 | 2025 | Tlando |
| Impulse Dynamics (USA) INC. | $16.17 | 2022 | |
| Inspire Medical Systems, INC. | $15.71 | 2025 | Inspire |
| Scilex Pharmaceuticals INC. | $15.20 | 2019 | |
| Lucid Diagnostics INC. | $14.54 | 2023 | |
| Renalytix Ai, INC. | $14.30 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| E.R. Squibb & Sons, L.L.C. | $14.28 | 2022 | |
| Clarus Therapeutics INC. | $13.38 | 2021 | |
| Avion Pharmaceuticals | $13.04 | 2023 | Balcoltra |
| Qiagen, LLC | $12.93 | 2022 | |
| Ironwood Pharmaceuticals, INC | $12.92 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.58 | 2020 | |
| Teleflex LLC | $12.06 | 2021 | |
| Amneal Pharmaceuticals LLC | $11.98 | 2020 | |
| Hikma Pharmaceuticals USA | $11.70 | 2020 | |
| Mayne Pharma Commercial LLC | $10.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Buschmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.